56 related articles for article (PubMed ID: 27257023)
1. Comparison of six hepatocellular carcinoma prediction models in Japanese patients after sustained virologic response undergoing rigorous surveillance for hepatocellular carcinoma.
Toyoda H; Tada T; Uojima H; Nozaki A; Chuma M; Takaguchi K; Hiraoka A; Abe H; Itobayashi E; Matsuura K; Atsukawa M; Watanabe T; Shimada N; Nakamuta M; Kojima M; Tsuji K; Mikami S; Ishikawa T; Yasuda S; Tsutsui A; Arai T; Kumada T; Tanaka Y; Tanaka J; Chayama K
J Gastroenterol Hepatol; 2024 May; 39(5):949-954. PubMed ID: 38291715
[TBL] [Abstract][Full Text] [Related]
2. Liver-related morbidity and mortality in patients with chronic hepatitis C and cirrhosis with and without sustained virologic response.
Hallager S; Ladelund S; Christensen PB; Kjær M; Thorup Roege B; Grønbæk KE; Belard E; Barfod TS; Madsen LG; Gerstoft J; Tarp B; Krarup HB; Weis N
Clin Epidemiol; 2017; 9():501-516. PubMed ID: 29123424
[TBL] [Abstract][Full Text] [Related]
3. A Healthy Liver After SVR: Food for Thought.
Rocque B; Kahn J; Emamaullee J
Dig Dis Sci; 2021 Jun; 66(6):1778-1779. PubMed ID: 32785795
[No Abstract] [Full Text] [Related]
4. Increased Duodenal Iron Absorption through Upregulation of Ferroportin 1 due to the Decrement in Serum Hepcidin in Patients with Chronic Hepatitis C.
Sato M; Miyanishi K; Tanaka S; Sakurada A; Sakamoto H; Kawano Y; Takada K; Kobune M; Kato J
Can J Gastroenterol Hepatol; 2018; 2018():2154361. PubMed ID: 30186818
[TBL] [Abstract][Full Text] [Related]
5. Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma.
Bandiera S; Billie Bian C; Hoshida Y; Baumert TF; Zeisel MB
Curr Opin Virol; 2016 Oct; 20():99-105. PubMed ID: 27741441
[TBL] [Abstract][Full Text] [Related]
6. American Gastroenterological Association Institute Clinical Practice Update-Expert Review: Care of Patients Who Have Achieved a Sustained Virologic Response After Antiviral Therapy for Chronic Hepatitis C Infection.
Jacobson IM; Lim JK; Fried MW
Gastroenterology; 2017 May; 152(6):1578-1587. PubMed ID: 28344022
[TBL] [Abstract][Full Text] [Related]
7. Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C.
Na SK; Song BC
Clin Mol Hepatol; 2019 Sep; 25(3):234-244. PubMed ID: 30661334
[TBL] [Abstract][Full Text] [Related]
8. Clinical Model for Predicting Hepatocellular Carcinomas in Patients with Post-Sustained Virologic Responses of Chronic Hepatitis C: A Case Control Study.
Zeng QL; Li B; Zhang XX; Chen Y; Fu YL; Lv J; Liu YM; Yu ZJ
Gut Liver; 2016 Nov; 10(6):955-961. PubMed ID: 27257023
[TBL] [Abstract][Full Text] [Related]
9. Serum sphingolipids predict de novo hepatocellular carcinoma in hepatitis C cirrhotic patients with sustained virologic response.
Mücke VT; Thomas D; Mücke MM; Waidmann O; Zeuzem S; Sarrazin C; Pfeilschifter J; Vermehren J; Finkelmeier F; Grammatikos G
Liver Int; 2019 Nov; 39(11):2174-2183. PubMed ID: 31207039
[TBL] [Abstract][Full Text] [Related]
10. Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin.
Ng KJ; Tseng CW; Chang TT; Tzeng SJ; Hsieh YH; Hung TH; Huang HT; Wu SF; Tseng KC
Clin Interv Aging; 2016; 11():1035-41. PubMed ID: 27536084
[TBL] [Abstract][Full Text] [Related]
11. Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents.
Calvaruso V; Cabibbo G; Cacciola I; Petta S; Madonia S; Bellia A; Tinè F; Distefano M; Licata A; Giannitrapani L; Prestileo T; Mazzola G; Di Rosolini MA; Larocca L; Bertino G; Digiacomo A; Benanti F; Guarneri L; Averna A; Iacobello C; Magro A; Scalisi I; Cartabellotta F; Savalli F; Barbara M; Davì A; Russello M; Scifo G; Squadrito G; Cammà C; Raimondo G; Craxì A; Di Marco V;
Gastroenterology; 2018 Aug; 155(2):411-421.e4. PubMed ID: 29655836
[TBL] [Abstract][Full Text] [Related]
12. Late development of hepatocellular carcinoma after viral clearance in patients with chronic hepatitis C: A need for continual surveillance.
Tong MJ; Theodoro CF; Salvo RT
J Dig Dis; 2018 Jul; 19(7):411-420. PubMed ID: 29889353
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and prognosis of HCC occurrence after antiviral therapy for HCV patients between sustained and non-sustained responders.
Sou FM; Wu CK; Chang KC; Lu SN; Wang JH; Hung CH; Chen CH; Kee KM; Yen YH; Lin MT; Tsai MC; Hu TH
J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):504-513. PubMed ID: 30527565
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for liver-related mortality in chronic hepatitis C patients: a deceased case-living control study.
Zeng QL; Feng GH; Zhang JY; Chen Y; Yang B; Huang HH; Zhang XX; Zhang Z; Wang FS
World J Gastroenterol; 2014 May; 20(18):5519-26. PubMed ID: 24833882
[TBL] [Abstract][Full Text] [Related]
15. All-cause mortality and liver-related outcomes following successful antiviral treatment for chronic hepatitis C.
Dieperink E; Pocha C; Thuras P; Knott A; Colton S; Ho SB
Dig Dis Sci; 2014 Apr; 59(4):872-80. PubMed ID: 24532254
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]